Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 2Not yet recruiting 1

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Lung Neoplasms 76Leukemia, Myeloid, Acute 70Prostatic Neoplasms 67Neoplasm Metastasis 56Carcinoma, Non-Small-Cell Lung 56Breast Neoplasms 45Multiple Myeloma 44Colorectal Neoplasms 40Pancreatic Neoplasms 36Myelodysplastic Syndromes 35Carcinoma, Renal Cell 33Ovarian Neoplasms 31Leukemia, Lymphocytic, Chronic, B-Cell 30Melanoma 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Glioblastoma 27Triple Negative Breast Neoplasms 26Lymphoma, Large B-Cell, Diffuse 26Urinary Bladder Neoplasms 24Lymphoma 23Burkitt Lymphoma 22Squamous Cell Carcinoma of Head and Neck 21Glioma 20Fallopian Tube Neoplasms 20Carcinoma, Hepatocellular 18Mouth Neoplasms 17Leukemia, Biphenotypic, Acute 17Brain Neoplasms 17Sarcoma 16Oropharyngeal Neoplasms 16

Interventions

Magnetic Resonance Spectroscopy 5Pentoxifylline 4Liver Transplantation 4Blood Specimen Collection 4Specimen Handling 3High-Energy Shock Waves 3Tocopherols 2Sorafenib 2Simvastatin 2Low-Level Light Therapy 2Gemcitabine 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1navitoclax 1maltodextrin 1esmolol 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1alpha-Tocopherol 1Viusid 1Vitamin E 1Vitamin D 1Tenofovir 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Fibrosis × Specimen Handling × Clear all
NCT02968810 2026-05-04

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

National Cancer Institute (NCI)

Phase 2 Active not recruiting
52 enrolled 15 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT07042919 2025-06-29

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Northwestern University

Phase 1/2 Not yet recruiting
53 enrolled
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT03278925 2024-08-02

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

National Cancer Institute (NCI)

Phase 1 Active not recruiting
14 enrolled

Fibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡